Passive immunity

Passive Immunity: Transient Protection

Passive immunity refers to the process by which individuals gain temporary protection against diseases through the transfer of antibodies produced by another human or animal. This article provides an in-depth look at the nature of passive immunity, its sources, duration, and its use in clinical settings.

Overview

Maternal antibodies being passed to an infant.

Passive immunity involves the direct transfer of active humoral immunity in the form of ready-made antibodies, from one individual to another. Unlike active immunity, where the individual's own immune system is activated to produce antibodies, passive immunity grants immediate, but temporary, protection.

Sources of Passive Immunity

The sources of passive immunity can be natural or artificial.

Natural Passive Immunity

Natural passive immunity occurs during pregnancy, where antibodies are passed from the maternal bloodstream to the fetus through the placenta. This provides the newborn with protection against infections in the early months of life. Breast milk also contains antibodies that contribute to passive immunity in infants.

Artificial Passive Immunity

Artificial passive immunity is provided by the administration of serum or immunoglobulin from an immunized individual to a non-immunized one, and it is used to prevent or treat diseases.

Mechanism of Action

Illustration of antibodies binding to antigens to neutralize them.

Passive immunity works by introducing antibodies, rather than antigens, to an individual’s immune system. These antibodies recognize and bind to pathogens, marking them for destruction or neutralizing them directly.

Duration and Efficacy

The protection offered by passive immunity is effective but short-lived, usually lasting only a few weeks to months. The body does not retain the memory of the antibodies once they are degraded, hence the protection is not lasting.

Clinical Applications

Passive immunity is used in several clinical scenarios:

• To provide immediate protection to individuals exposed to a recent outbreak or to a high-risk pathogen.
• In the treatment of certain diseases, such as immunodeficiencies, where patients cannot produce sufficient antibodies on their own.
• As post-exposure prophylaxis against diseases like hepatitis B, rabies, and certain types of poisoning.

Challenges and Considerations

While passive immunity can be lifesaving, it has limitations. It may cause allergic reactions, and there is a potential for the transmission of blood-borne pathogens when serum is used. Moreover, the introduction of external antibodies can sometimes suppress the recipient’s active immunity.

Conclusion

Passive immunity remains a crucial component of preventive medicine and therapeutics. Ongoing research aims to enhance the safety and efficacy of passive immunization strategies.

Passive immunity Resources
Latest articles Most recent articles Ongoing trials	Wikipedia